This application is an informational app; It presents information from the NIH pertaining to depression. Included are sections on Symptoms, Causes, Diagnosis, and Treatments. There are also sections on specialized topics such as Depression in Women, Depression in Men, Depression in the Elderly, and Depression in Children.
Available for: Android 2.1 or later
Company Name: Incelligence
Classification (Type of Treatment): Psychoeducation/Informational
Targeted conditions: Mood disorders
Target demographics: Not specified
Special provider necessary: No
Languages Available in: English
Where to get it: Google Play
Expert ratings and reviews
PsyberGuide rating: The research and support basis of the product
Total Score: 2/14
Basis of research: 0
Source of funding for the research: 0
Specificity of the proposed intervention: 0
Number of consumer ratings: 2
Product advisory support: 0
Software support: 0
date of rating: December 2017
Quality scores range from 1 to 5, where 5 is the maximum scoreNot yet available
Research on the product
This app provides psychoeducation for depression. Psychoeducation is usually used as a comparison condition to represent an inert treatment for which an active treatment can be compared (e.g., Ebert et al., 2014). However, a meta-analysis of psychoeducation for depression and anxiety found that brief, passive psychoeducational interventions can be effective at reducing depression, albeit with small effect sizes (Donker, Griffiths, Cuijpers, & Christensen, 2004). Therefore, psychoeducation may be a useful first-step intervention for those suffering from depression.
Ebert, D. D., Lehr, D., Baumeister, H., Boß, L., Riper, H., Cuijpers, P., … & Berking, M. (2014). GET. ON Mood Enhancer: efficacy of Internet-based guided self-help compared to psychoeducation for depression: an investigator-blinded randomised controlled trial. Trials, 15(1), 39
Donker, T., Griffiths, K. M., Cuijpers, P., & Christensen, H. (2009). Psychoeducation for depression, anxiety and psychological distress: a meta-analysis. BMC medicine, 7(1), 79.